Stonepine Capital Management »

Elevation Oncology shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $113k 200k 0.56

More positions owned by Stonepine Capital Management

Verastem Com New (VSTM)
Adma Biologics (ADMA)
Evolus (EOLS)
Zevra Therapeutics Com New (ZVRA)
Nektar Therapeutics Com New (NKTR)
Day One Biopharmaceuticals I (DAWN)
Xoma Royalty Corporation Com New (XOMA)
ACADIA Pharmaceuticals (ACAD)
Enanta Pharmaceuticals (ENTA)
X4 Pharmaceuticals Com New (XFOR)
Omniab (OABI)
Surrozen Com New (SRZN)
Tela Bio (TELA)
Indivior Ord (INDV)
Abeona Therapeutics Com New (ABEO)

View all positions for Stonepine Capital Management

Top funds holding Elevation Oncology

Morgan Stanley
Advisor Group Holdings

View all funds holding Elevation Oncology